EGFR and neoplasm: EGFR mutations are usually accompanied with prolonged signaling that is associated with metastasis, angiogenesis, apoptosis inhibition, and enhanced proliferation of the tumor cells (Nagane et al., 1996; Sangar et al., 2014).